The Additional Effect of Hallux Valgus Correction on Runners With First Ray Instability and Patellofemoral Pain Syndrome

May 31, 2018 updated by: National Yang Ming University

The Additional Effect of First Metatarsophalangeal Joint Correction on Runners With First Ray Instability and Patellofemoral Pain Syndrome

The study purpose is to investigate the effectiveness of a program combining biomechanical taping with lower extremity neuromuscular exercises for runners with patellofemoral pain syndrome (PFPS) and hallux valgus

Study Overview

Detailed Description

This will be a single-blind, experimental study with two treatment groups. A total of 30 college athletes with PFPS and hallux valgus and majoring in long distance running or soccer, or recreational runners in Taipei metropolitan area will be recruited. A set of clinical examination will be conducted to rule out abnormal knee structures, pathologies, or injuries apart from PFPS. The lower extremity alignment as well as hip and knee kinematics during a step down test will be tracked using Noraxon's myoMOTION system. Muscle activation of the muscles controlling the hip and knee movements during the step down test will be recorded using TELEmyo DTS of Noraxon. Hallux valgus angle will be measured with surface markers on photographs. Knee pain level will be rated in a visual analog scale. The investigators will analyze the data with Statistical Product and Service Solutions (SPSS) for Windows. Repeated-measure ANOVAs will be used to examine group-by-time interaction on all the outcome variables. All significance level will be set at 0.05.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • High physical activity level (running at least 5 times/week and at least 2 hours/time)
  • Presenting anterior/retropatellar knee pain in the past 6 months
  • At least two of the following activities provocated symptom: Prolonged sitting, ascending and/or descending stairs, squatting, kneeling, running, limping
  • Not having any pathologies of knee joint (ligament tear, menisci injury, patellofemoral joint dislocation, tendinitis, bursitis…etc.)
  • With hallux valgus angle>15°
  • With 1st metatarsophalangeal joint instability
  • 20~40 y/o

Exclusion Criteria:

  • Lower extremities osteoarthritis
  • Systematic diseases such as rheumatoid arthritis, systemic lupus erythematosus, DM…etc.
  • Lower extremities fracture history
  • Surgical history of lower extremities
  • Neurological pathology that would interfere with gait
  • Hallux could not be corrected to neutral through passive correction
  • Low back pain and/or sacroiliac joint dysfunction in the past six months
  • Excessive femoral anteversion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Combined training group
Biomechanical taping will first being applied to the participants of the combined training group. They will be asked to perform following exercises in this session afterwards. As the treatment session goes on, a set of foot intrinsic muscle strengthening exercise and lower extremity neuromuscular exercise will be provided.
The whole intervention period will last for 6 weeks, 2 visits per week, 1 hour per visit in the Research Building Room 630 of National Yang Ming University. All programs will be under the supervision of a physiotherapist with 2-year experience individually. 1. Hallux valgus correction: 1.1 Joint alignment correction (Grade II joint mobilization, 10 times/set, 3 sets/visit) - 1st MTP joint distraction - Proximal talofibular joint anteroposterior glide - (Grade III joint mobilization if any restriction being found) 1.2 Biomechanical taping (using Dynamic taping, 1 time/ visit, keep the taping for 2 days minimum) 1.3 Foot intrinsic muscle strengthening (10 times/set for each exercise, 3 sets/visit): - Short foot exercise - Toespread out exercise - Heel-rise exercises 2. Lower extremity neuromuscular exercises: (10-15 times/set, 3 sets/visit) 2.1 Single lunge 2.2 Stepping down 2.3 Vertical squat 2.4 Vertical jumping
Other Names:
  • hallux valgus correction
  • lower extremity neuromuscular exercises
Active Comparator: Proximal training group
For participants of the proximal training group, only a set of lower extremity neuromuscular exercise will be provided. This set of exercises is designed to be the same as for participants of combined training group.
1. Lower extremity neuromuscular exercises: (10-15 times/set, 3 sets/visit) 1.1 Single lunge 1.2 Stepping down 1.3 Vertical squat 1.4 Vertical jumping All exercises will first start on firm surface without additional resistance/weight. Later, settings will be gradually shifted into on firm surface with resisted band from random direction, on a cushion with/ without resisted band, on a BOSU balance trainer. Progression are made every 2 weeks ideally, while adjustments may be taken into concern due to individual differences.
Other Names:
  • lower extremity neuromuscular exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Displacement of femur in step-down test
Time Frame: changes from baseline and after 6 weeks of intervention
displacement recorded in cm/BMI
changes from baseline and after 6 weeks of intervention
Displacement of tibia in step-down test
Time Frame: changes from baseline and after 6 weeks of intervention
displacement recorded in cm/BMI
changes from baseline and after 6 weeks of intervention
Knee pain level
Time Frame: changes from baseline and after 6 weeks of intervention
The level of knee pain during daily activities will be quantified with visual analogue scale.
changes from baseline and after 6 weeks of intervention
Changes of pain-free running distance
Time Frame: changes from baseline and after 6 weeks of intervention
The changes of pain-free running distance will be recorded in kilometers.
changes from baseline and after 6 weeks of intervention
EMG amplitude of knee extensor
Time Frame: changes from baseline and after 6 weeks of intervention
amplitude recorded in %MVC
changes from baseline and after 6 weeks of intervention
EMG amplitude of knee flexor
Time Frame: changes from baseline and after 6 weeks of intervention
amplitude recorded in %MVC
changes from baseline and after 6 weeks of intervention
EMG amplitude of hip external rotator
Time Frame: changes from baseline and after 6 weeks of intervention
amplitude recorded in %MVC
changes from baseline and after 6 weeks of intervention
changes of the muscle activation time between vastus medialis oblique and vastus lateralis
Time Frame: changes from baseline and after 6 weeks of intervention
changes of the muscle activation time recorded in second
changes from baseline and after 6 weeks of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tibiofemoral angle in relaxed standing
Time Frame: changes from baseline and after 6 weeks of intervention
recorded in degree
changes from baseline and after 6 weeks of intervention
Hallux valgus angle in relaxed standing
Time Frame: changes from baseline and after 6 weeks of intervention
recorded in degree
changes from baseline and after 6 weeks of intervention
Navicular drop
Time Frame: changes from baseline and after 6 weeks of intervention
navicular position changes between sitting and relaxed standing, recording in cm
changes from baseline and after 6 weeks of intervention
Arch height index
Time Frame: changes from baseline and after 6 weeks of intervention
arch height in one leg standing, recording in the ratio of arch height and truncated foot length
changes from baseline and after 6 weeks of intervention
Hip rotation angle in relaxed standing
Time Frame: changes from baseline and after 6 weeks of intervention
recorded in degree
changes from baseline and after 6 weeks of intervention
Knee rotation angle in relaxed standing
Time Frame: changes from baseline and after 6 weeks of intervention
recorded in degree
changes from baseline and after 6 weeks of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: be945a7ts@gmail.com Chen, PhD, National Yang Ming University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 20, 2018

Primary Completion (Anticipated)

September 30, 2018

Study Completion (Anticipated)

October 31, 2018

Study Registration Dates

First Submitted

February 6, 2018

First Submitted That Met QC Criteria

March 11, 2018

First Posted (Actual)

March 16, 2018

Study Record Updates

Last Update Posted (Actual)

June 1, 2018

Last Update Submitted That Met QC Criteria

May 31, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Clinical Trials on combined training

3
Subscribe